Skip to main content
OpenTrials
Completed

NCT Number: NCT02607267

Edmonton Obesity Staging System: Post-operative Outcome and 30-day Mortality

The Edmonton Obesity Staging System (EOSS) is a more comprehensive measure of obesity-related diseases and predictor of mortality than BMI or waist circumference. The aim of this study is to determine whether the EOSS is also important in predicting post - operative outcome and 30-day mortality after metabolic surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Complications Other Complications of Other Bariatric Procedure Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

19 year–73 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sana Klinikum Offenbach

Offenbach, Hesse, 63069, Germany

About this study

From October 2014 to December 2015 the investigators conducted a prospective data collection on patients undergoing either laparoscopic sleeve gastrectomy (LSG) or laparoscopic Gastric Bypass (Laparoscopic Roux-en-Y-Gastric Bypass (LRYGB) and Omega-Loop-Gastric-Bypass (LOLGB)), being the first surgical treatment for severe obesity. Preoperative EOSS by Sharma et al. was applied to all patients by two different evaluators. Data collection included the following: gender, age, body mass index, waist circumference, waist to hip ratio, comorbidities, early - postoperative complications, readmission rates and 30 - day mortality. Follow-up was performed in all patients up to 1 month after surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients undergoing either LSG or LRYGB, being the first surgical treatment for severe obesity

Exclusion criteria

  • bariatric surgery in the anamnesis

Treatment and study plan

LSG and LRYGB

Other

The role of the Edmonton Obesity Staging System in predicting post-operative outcome and 30-day mortality after metabolic surgery (LSG and LRYGB)

Primary outcomes

  1. postoperative outcome related to EOSS

    Time frame: 30 days after surgery

Secondary outcomes

  1. postoperative complications related to EOSS

    Time frame: 30 days after surgery

  2. readmission rates related to EOSS

    Time frame: 30 days after surgery

  3. age related to postoperative complications

    Time frame: 30 days after surgery

  4. BMI related to postoperative complications

    Time frame: 30 days after surgery

Sponsors and collaborators

Lead sponsor

Sana Klinikum Offenbach

Other

Registry information

Official study title

The Importance of the Edmonton Obesity Score System in Predicting Postoperative Outcome and 30 Day Mortality After Metabolic Surgery

Important dates

Study start
2014
Primary completion
2015
Study completion
2016
First posted
Nov 18, 2015
Registry last updated
Apr 25, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.